Skip to main content

Table 2 Serum concentrations of LBP and sCD14 as related to metabolic syndrome and its separate constituents

From: Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study

  LBP (µg/mL) p sCD14 (ng/mL) p
MetS
 + 13.1 (11.2, 15.5) 0.11 1285 (1057, 1483) 0.71
 – 12.7 (10.3, 14.9) 1306 (1053, 1538)
Waist circumference
 > 102 cm 13.2 (11.2, 15.7) 0.04 1299 (1078, 1494) 0.41
 ≤ 102 cm 12.6 (10.2, 14.9) 1294 (1033, 1535)
Blood pressure
 > 130/85 mmHg 12.9 (10.5, 15.2) 0.87 1294 (1051, 1499) 0.36
 ≤ 130/85 mmHg 13.0 (10.9, 15.0) 1309 (1053, 1627)
Fasting glucose
 ≥ 5.6 mmol/L 12.9 (10.5, 15.3) 0.99 1299 (1065, 1494) 0.95
 < 5.6 mmol/L 12.9 (10.6, 15.0) 1293 (1004, 1566)
HDL-cholesterol
 < 1.04 mmol/L 13.8 (11.1, 15.9) 0.15 1309 (1039, 1594) 0.72
 ≥ 1.04 mmol/L 12.8 (10.5, 15.1) 1295 (1052, 1518)
Triglycerides
 > 1.7 mmol/L 13.0 (10.8, 15.4) 0.69 1284 (1061, 1495) 0.87
 ≤ 1.7 mmol/L 12.7 (10.4, 15.0) 1297 (1030, 1530)
Fasting glucose
 ≤ 5.5 12.9 (10.6, 15.0) 0.99* 1289 (1008, 1558) 0.71*
 5.6–6.9 12.8 (10.6, 15.1) 1297 (1072, 1467)
 ≥ 7.0 13.1 (10.5, 15.3) 1317 (1056, 1589)
  1. Median values are given (25, 75 percentiles). P-values refers to differences between groups. * Kruskall–Wallis test. Italic text indicates p-values below < 0.05